| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.36 |
4e-21 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
3e-20 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
3e-19 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
2e-18 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
1e-16 |
| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
9e-16 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
5e-15 |
| mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
9e-14 |
| mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
1e-13 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
3e-13 |